Literature DB >> 6770287

Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.

H L Bonkowsky, P R Sinclair, S Emery, J F Sinclair.   

Abstract

Seizures may occur in acute intermittent porphyria or other hepatic porphyrias. Management is difficult, because barbiturates and hydantoins exacerbate the porphyric state. We studied one patient with major motor seizures and acute intermittent porphyria. The seizure disorder was exacerbated by phenytoin and did not respond to a high-carbohydrate diet or to intravenous hematin. Clonazepam was ineffective in treating the seizures and, in high doses, seemed to exacerbate the porphyria. Both clonazepam and valproate were porphyrinogenic in experimental test systems. Because both drugs may exacerbate the acute hepatic porphyrias, bromide remains the drug of choice to treat these seizures.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770287     DOI: 10.1212/wnl.30.6.588

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  Diagnosis and management of porphyria.

Authors:  H Thadani; A Deacon; T Peters
Journal:  BMJ       Date:  2000-06-17

2.  Acute intermittent porphyria presenting as epilepsy.

Authors:  A C Scane; J P Wight; R B Godwin-Austen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

3.  An elusive case of acute abdomen.

Authors:  Vivek Aggarwal; Deepak Dwivedi; A V Akulwar
Journal:  Med J Armed Forces India       Date:  2011-10-22

4.  Effect of anticonvulsant drugs on serum delta-aminolaevulinic acid levels in non-porphyric subjects.

Authors:  A Gorchein; R Webber; D Burnett; J H Goudie
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  Coexistence of hereditary coproporphyria and epilepsy: coproporphyrinogen oxidase deficiency in liver and kidney.

Authors:  M Doss; R von Tiepermann; K H Pflüger
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

6.  Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.

Authors:  H L Bonkovsky; J F Healey; P R Sinclair; J F Sinclair
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

Review 7.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

8.  A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.

Authors:  E Perucca; A Hedges; K A Makki; M Ruprah; J F Wilson; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

9.  The "glucose effect" in acute hepatic porphyrias and in experimental porphyria.

Authors:  M Doss; F Verspohl
Journal:  Klin Wochenschr       Date:  1981-07-01

10.  Effects of valproate on xenobiotic biotransformation in rat liver. In vivo and in vitro experiments.

Authors:  V Rogiers; A Callaerts; A Vercruysse; M Akrawi; E Shephard; I Phillips
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.